Becton, Dickinson and Company (BIT:1BDX)

Market Cap	42.20B -39.0%
Revenue (ttm)	18.67B +6.2%
Net Income	1.50B +1.7%
EPS	5.22 +3.1%
Shares Out	n/a
PE Ratio	28.20
Forward PE	13.90
Dividend	2.75 (1.86%)
Ex-Dividend Date	Dec 5, 2025

Volume	n/a
Average Volume	10
Open	148.45
Previous Close	148.45
Day's Range	148.45 - 148.45
52-Week Range	110.77 - 186.30
Beta	n/a
RSI	30.89
Earnings Date	Feb 9, 2026

About BIT:1BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1897
• Employees: 72,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1BDX

Financial Performance

In fiscal year 2025, BIT:1BDX's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD